Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M140Revenue (TTM) $M59.6Net Margin (%)-119.6Altman Z-Score-41.2
Enterprise Value $M-40.5EPS (TTM) $-0.3Operating Margin %-117.2Piotroski F-Score5
P/E(ttm)--Beneish M-Score-0.3Pre-tax Margin (%)-121.5Higher ROA y-yY
Price/Book3.510-y EBITDA Growth Rate %-55.8Quick Ratio1.4Cash flow > EarningsN
Price/Sales0.95-y EBITDA Growth Rate %-29.2Current Ratio1.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-70.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-250.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M282ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with CTIC

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CTIC is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CTIC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BIANCO JAMES APresident and CEO 2016-06-24Sell10,000$0.3735.14view
BIANCO JAMES APresident and CEO 2016-05-27Sell10,000$0.4511.11view
BIANCO JAMES APresident and CEO 2016-04-29Sell10,000$0.52-3.85view
BIANCO JAMES APresident and CEO 2016-03-28Sell10,000$0.492.04view
BIANCO JAMES APresident and CEO 2016-03-21Sell318,169$0.55-9.09view
Plunkett MatthewEVP, Chief Business Officer 2016-03-04Sell10,000$0.59-15.25view
BIANCO JAMES APresident and CEO 2016-02-26Sell10,000$0.63-20.63view
SINGER JACK WEVP, Chief Scientific Officer 2016-02-26Sell15,000$0.63-20.63view
BIANCO JAMES APresident and CEO 2016-02-16Sell100,000$0.4219.05view
Plunkett MatthewEVP, Chief Business Officer 2016-02-04Sell10,000$1.15-56.52view

Press Releases about CTIC :

Quarterly/Annual Reports about CTIC:

News about CTIC:

Articles On GuruFocus.com
Monday Morning Pre-Market Insights: Celldex Therapeutics, Celladon Corp, CTI BioPharma Corp, TG Ther Jun 01 2015 
Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc., Standard Pacific Corp and Dollar G Mar 24 2014 
These 4 Biotech Stocks Are a Buy Now Feb 08 2012 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Feb 25 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Jan 28 2011 
Weekly CEO Sells Highlight: CTIC, DDR, UNM, BRCM, TC Jan 09 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 250,000 Shares Jan 03 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 200,000 Shares Dec 17 2010 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 150,000 Shares Dec 10 2010 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 100,000 Shares Nov 05 2010 

More From Other Websites
10:36 am CTI BioPharma announces the PERSIST-2 Phase 3 study of pacritinib vs best available therapy... Dec 06 2016
PERSIST-2 Phase 3 Study Of Pacritinib Versus Best Available Therapy Shows Encouraging Clinical... Dec 06 2016
ETFs with exposure to CTI BioPharma Corp. : December 2, 2016 Dec 02 2016
CTI BioPharma Presents Nonclinical Pharmacology Study Demonstrating Pacritinib Has Distinct Profile... Dec 01 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Nov 30 2016
CTI BIOPHARMA CORP Financials Nov 30 2016
CTI BioPharma Announces Phase 3 Data from the PERSIST-2 Trial of Pacritinib to be Presented in... Nov 21 2016
BrainStorm Cell Therapeutics Reports Third Quarter 2016 Financial Results Nov 15 2016
ETF’s with exposure to CTI BioPharma Corp. : November 10, 2016 Nov 10 2016
CTI BioPharma Corp. :CTIC-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016 Nov 09 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 08 2016
CTI BioPharma reports 3Q loss Nov 08 2016
CTI BioPharma reports 3Q loss Nov 08 2016
CTI BioPharma Reports Third Quarter 2016 Financial Results Nov 08 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Oct 31 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a... Oct 24 2016
5 Biotech Penny Stocks Smart Money Is Piling On Oct 23 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Oct 03 2016
CTI BioPharma Announces Retirement Of President And CEO Oct 03 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Sep 29 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)